All Articles

New Alzheimer's Drug: A Beacon of Hope?

Biogen and Eisai’s Alzheimer’s drug Leqembi slows early cognitive decline, but high costs and access gaps spark controversy.

4 min read

Stay connected to the evolving world of healthcare.

Health Services & System News brings you timely updates, expert commentary, and essential resources straight to your inbox.

Email*

Yes, subscribe me to your newsletter.